Trials (University Medical Center Groningen Comprehensive Cancer Center): Revision history

15 December 2025

• curprev 17:1517:15, 15 December 2025‎ Francine talk contribs‎ 111,362 bytes +193‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 111,169 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:3117:31, 4 December 2025‎ Larysse talk contribs‎ 109,468 bytes +56‎ No edit summary undo

2 December 2025

• curprev 14:0114:01, 2 December 2025‎ Lucas talk contribs‎ m 109,412 bytes +90‎ Update categories. undo

5 December 2023

• curprev 18:2518:25, 5 December 2023‎ Francine talk contribs‎ 109,322 bytes +109,322‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to University Medical Center Groningen Comprehensive Cancer Center page '''NCTID''': NCT03719690 '''Title''': Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy '''Study Summary''': An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). Th..."